Used in pharmaceutical research as a key intermediate for developing potent serotonin reuptake inhibitors. Shows promise in the synthesis of novel antidepressant agents due to its ability to cross the blood-brain barrier effectively. Also employed in structure-activity relationship (SAR) studies to optimize binding affinity toward monoamine transporters. Its sulfonamide and benzamide moieties contribute to enhanced metabolic stability and target selectivity in central nervous system drug candidates.